These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15252212)

  • 1. Antibody response to the human stress protein BiP in rheumatoid arthritis.
    Bodman-Smith MD; Corrigall VM; Berglin E; Cornell HR; Tzioufas AG; Mavragani CP; Chan C; Rantapää-Dahlqvist S; Panayi GS
    Rheumatology (Oxford); 2004 Oct; 43(10):1283-7. PubMed ID: 15252212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The stress protein BiP is overexpressed and is a major B and T cell target in rheumatoid arthritis.
    Bläss S; Union A; Raymackers J; Schumann F; Ungethüm U; Müller-Steinbach S; De Keyser F; Engel JM; Burmester GR
    Arthritis Rheum; 2001 Apr; 44(4):761-71. PubMed ID: 11315915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synovial fluid expression of autoantibodies specific for RAGE relates to less erosive course of rheumatoid arthritis.
    Pullerits R; Bokarewa M; Dahlberg L; Tarkowski A
    Rheumatology (Oxford); 2007 Aug; 46(8):1367-71. PubMed ID: 17569744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of anti-3-nitrotyrosine antibodies in the joint synovial fluid of patients with rheumatoid arthritis, osteoarthritis and systemic lupus erythematosus.
    Khan F; Siddiqui AA
    Clin Chim Acta; 2006 Aug; 370(1-2):100-7. PubMed ID: 16513103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis.
    Xue Y; Zhang J; Chen YM; Guan M; Zheng SG; Zou HJ
    Scand J Rheumatol; 2008; 37(3):183-7. PubMed ID: 18465452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
    Greiner A; Plischke H; Kellner H; Gruber R
    Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycoplasma fermentans in rheumatoid arthritis and other inflammatory arthritides.
    Horowitz S; Evinson B; Borer A; Horowitz J
    J Rheumatol; 2000 Dec; 27(12):2747-53. PubMed ID: 11128659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High diagnostic value of anticalpastatin autoantibodies in rheumatoid arthritis detected by ELISA using human erythrocyte calpastatin as antigen.
    Iwaki-Egawa S; Matsuno H; Yudoh K; Nakazawa F; Miyazaki K; Ochiai A; Hirohata S; Shimizu M; Watanabe Y
    J Rheumatol; 2004 Jan; 31(1):17-22. PubMed ID: 14705213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.
    Matsui T; Shimada K; Ozawa N; Hayakawa H; Hagiwara F; Nakayama H; Sugii S; Ozawa Y; Tohma S
    J Rheumatol; 2006 Dec; 33(12):2390-7. PubMed ID: 16924694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement characteristics of a new rapid anti-CCP2 test compared to the anti-CCP2 ELISA.
    Snijders GF; Broeder AA; Bevers K; Jeurissen ME; van Eerd JE; van den Hoogen FH
    Scand J Rheumatol; 2008; 37(2):151-4. PubMed ID: 18415774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis.
    Dejaco C; Klotz W; Larcher H; Duftner C; Schirmer M; Herold M
    Arthritis Res Ther; 2006; 8(4):R119. PubMed ID: 16859519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgG, IgA, IgM antibodies to a viral citrullinated peptide in patients affected by rheumatoid arthritis, chronic arthritides and connective tissue disorders.
    Anzilotti C; Riente L; Pratesi F; Chimenti D; Delle Sedie A; Bombardieri S; Migliorini P
    Rheumatology (Oxford); 2007 Oct; 46(10):1579-82. PubMed ID: 17717033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
    Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O
    Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection.
    Lim MK; Sheen DH; Lee YJ; Mun YR; Park M; Shim SC
    J Rheumatol; 2009 Apr; 36(4):712-6. PubMed ID: 19286846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-p53 antibodies are rarely detected in serum of patients with rheumatoid arthritis and Sjögren's syndrome.
    Mariette X; Sibilia J; Delaforge C; Bengoufa D; Brouet JC; Soussi T
    J Rheumatol; 1999 Aug; 26(8):1672-5. PubMed ID: 10451060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis.
    Soós L; Szekanecz Z; Szabó Z; Fekete A; Zeher M; Horváth IF; Dankó K; Kapitány A; Végvári A; Sipka S; Szegedi G; Lakos G
    J Rheumatol; 2007 Aug; 34(8):1658-63. PubMed ID: 17611988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to the endoplasmic reticulum-resident chaperones calnexin, BiP and Grp94 in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Weber CK; Haslbeck M; Englbrecht M; Sehnert B; Mielenz D; Graef D; Distler JH; Mueller RB; Burkhardt H; Schett G; Voll RE; Fürnrohr BG
    Rheumatology (Oxford); 2010 Dec; 49(12):2255-63. PubMed ID: 20716673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-xanthine oxidase antibodies in sera and synovial fluid of patients with rheumatoid arthritis and other joint inflammations.
    Arrar L; Hanachi N; Rouba K; Charef N; Khennouf S; Baghiani A
    Saudi Med J; 2008 Jun; 29(6):803-7. PubMed ID: 18521455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are there autoantibodies reacting against citrullinated peptides derived from type I and type II collagens in patients with rheumatoid arthritis?
    Koivula MK; Aman S; Karjalainen A; Hakala M; Risteli J
    Ann Rheum Dis; 2005 Oct; 64(10):1443-50. PubMed ID: 16162901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isotype distribution of anti-cyclic citrullinated peptide antibodies in undifferentiated arthritis and rheumatoid arthritis reflects an ongoing immune response.
    Verpoort KN; Jol-van der Zijde CM; Papendrecht-van der Voort EA; Ioan-Facsinay A; Drijfhout JW; van Tol MJ; Breedveld FC; Huizinga TW; Toes RE
    Arthritis Rheum; 2006 Dec; 54(12):3799-808. PubMed ID: 17133560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.